2BB score and signals
Lyell Immunopharma, Inc.’s current 2BB score is 49 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 51 | Moderate |
| Momentum | 34 | Weakening |
| Financial strength | 15 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 49 | Moderate |
Company facts
| Headquarters | South San Francisco, California, United States |
| Founded | 2018 |
| Employees | 161 |
| 52-week range | $10.29 – $45.00 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-09 | — | -2.1063 | — | $2,682.00 |
| 2026-08-10 | — | -2.0648 | — | $3,906.00 |
| 2026-05-11 | — | -2.1094 | — | $6,456.00 |
| 2026-03-09 | — | -2.4174 | — | $0.00 |
Related companies
2BBBullish & Bearish